Arphra AIPlain-English read on Royalty Pharma plc’s valuation
Valuation read
Rich vs self
Each multiple is placed against its own 5-year range (the dot is the historical percentile of today’s value) and the peer-set sector median. key_metrics_ttm
Multiples · current vs 5-year range vs sector
marker = today’s percentile · sector = peer median
Metric
Current
5-year range
%ile
Sector
Read
P / E (TTM)
—
—
—
—
—
PEG
—
—
—
—
—
EV / EBITDA
18.3×
18.3
18.3
100
—
rich vs its history
EV / Sales
12.8×
12.8
13.3
25
—
cheap vs its 5y range
P / S
—
—
—
—
—
P / B
—
—
—
—
—
EV / FCF
11.7×
11.7
12.2
25
—
cheap vs its 5y range
FCF yield
11.65%
11.0
11.7
100
—
rich vs its history
Pro
Multiples
Valuation multiples and peer comparisons are included with Pro.